Publications

Title

Author

Year

Impaired natural killer cell responses to vaccine antigens in human cytomegalovirus-infected individuals.

Nielsen, CM; White, MJ; Rodriguez-Galan, A; BOTTOMLEY, C; Turner, SE G; GOODIER, MR; Riley, EM;

2014

IMMUNOLOGY, (2014).143,

Serological screening of six soluble Chlamydia trachomatis antigens for use in trachoma candidate vaccine studies.

Pickering, H; Tetteh, K; Hayward, RD; HOLLAND, MJ;

2014

IMMUNOLOGY, (2014).143,

Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: a nested case-control study.

Wakeham, K; Johnston, WT; NALWOGA, A; WEBB, EL; Mayanja, BN; Miley, W; ELLIOTT, AM; Whitby, D; NEWTON, R;

2014

International journal of cancer Journal international du cancer, (2014).136 12 10.1002/ijc.29329.

Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation.

LARSON, HJ; WILSON, R; Hanley, S; Parys, A; PATERSON, P;

2014

Human vaccines & immunotherapeutics, (2014).10 9 10.4161/21645515.2014.969618.

CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.

Musson, JA; Reynolds, CJ; Rinchai, D; Nithichanon, A; Khaenam, P; Favry, E; SPINK, N; Chu, KK Y; De Soyza, A; BANCROFT, GJ; Lertmemongkolchai, G; Maillere, B; Boyton, RJ; Altmann, DM; Robinson, JH;

2014

Journal of immunology (Baltimore, Md, (2014).193 12 10.4049/jimmunol.1402273.

Authors' reply to Gandjour: "Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines".

Newall, AT; JIT, M; Hutubessy, R;

2014

PharmacoEconomics, (2014).32 12 10.1007/s40273-014-0232-0.

Vaccine-preventable travel health risks: what is the evidence--what are the gaps?.

Steffen, R; BEHRENS, RH; Hill, DR; Greenaway, C; Leder, K;

2014

Journal of travel medicine, (2014).22 1 10.1111/jtm.12171.

Impact of co-infections and BCG immunisation on immune responses among household contacts of tuberculosis patients in a Ugandan cohort.

Biraro, IA; EGESA, M; TOULZA, F; Levin, J; COSE, S; Joloba, M; SMITH, S; DOCKRELL, HM; Katamba, A; ELLIOTT, AM;

2014

PloS one, (2014).9 11 10.1371/journal.pone.0111517.

Early indication for a reduced burden of radiologically confirmed pneumonia in children following the introduction of routine vaccination against Haemophilus influenzae type b in Nha Trang, Vietnam.

FLASCHE, S; Takahashi, K; Vu, DT; Suzuki, M; Nguyen, TH-A; Le, H; Hashizume, M; Dang, DA; Edmond, K; Ariyoshi, K; MULHOLLAND, EK; EDMUNDS, WJ; Yoshida, L-M;

2014

Vaccine, (2014).32 51 10.1016/j.vaccine.2014.10.055.

Methods for Health Economic Evaluations of Vaccines - Results from an International Expert-Workshop.

Ultsch, B; Damm, O; Beutels, P; Bilcke, J; Brüggenjürgen, B; Gerber-Grote, AU; Greiner, W; Hanquet, G; Harder, T; Hutubessy, R; JIT, M; Knol, M; Kuhlmann, A; Von Kries, R; Levy-Bruhl, D; Perleth, M; Postma, MJ; Salo, H; Siebert, U; Wasem, J; Weidemann, F; Wichmann, O;

2014

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, (2014).17 7 10.1016/j.jval.2014.08.1803.